Harvard Bioscience (NASDAQ:HBIO) Rating Lowered to “Hold” at StoneX
Harvard Bioscience (NASDAQ:HBIO – Get Free Report) was downgraded by StoneX from a “speculative buy” rating to a “hold” rating in a research note issued to investors on Wednesday, Marketbeat.com reports. HBIO has been the subject of several other research reports. Weiss Ratings upgraded shares of Harvard Bioscience from a “sell (e+)” rating to a […]
13 Nov 06:54 · The Markets Daily